好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Study of Onboarding for Neurology APPs (SONAr): Lessons Learned from the 1-year Interim Data Analysis
好色先生, Research, and Methodology
P12 - Poster Session 12 (11:45 AM-12:45 PM)
5-016

To describe typical longitudinal development of self-efficacy and entrustment of new neurology advanced practice providers (APPs) over their first year of practice.

APPs are key contributers to neurology teams. However, APP degree programs offer limited clinical neurology education. On-the-job training is critical for ensuring success in neurologic practice, but data to inform best practices are limited.

This was a prospective, multi-center, longitudinal survey-based study. Participants were APPs in their first year of neurology practice across the United States. We developed a survey instrument to evaluate participant training activities, self-efficacy, and entrustment. The survey was administered at 0-, 1-, 3-, 6-, and 12-months post-start date.

Through one year, 26 participants (14 outpatient, 8 inpatient, 2 hybrid; 14 physician assistants, 12 nurse practitioners) have been enrolled, completeing 65 individual surveys. A neurology APP fellowship was previously completed by 5 participants. Participants reported engaging in 4-5 hours of reading per week in the first 3 months but only reported 1-1.5 hours of didactic time per week throughout the first year. Only one participant reported any simulation training at any time point. Compared with other diseases, participants reported highest self-efficacy in headache management (62.0-82.4, 100-point self-efficacy scale) and lowest self-efficacy in brain tumor management (26.3-39.9) throughout the study. Self-efficacy in epilepsy management increased most (39.9-69.1). By month 3, most participants reported typically taking a history (11/14) and performing an exam (13/14) without a supervisor immediately available. By 6 months, only 5/10 participants reported most often recommending and interpreting diagnostic testing without a supervisor immediately available.

Training activities for new neurology APPs are mostly self-directed. Neuro-oncology and recommending and interpreting diagnostic testing may be unique educational needs for these clinicians. Enrollment of additional participants will facilitate between group comparisons to determine which educational strategies most effectively foster entrustment and self-efficacy among new neurology APPs.

Authors/Disclosures
Daniel S. Harrison, MD (Boston Medical Center)
PRESENTER
Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Diedrich & Donohue, LLP.
Margaret Naclerio, PA (Brigham and Women's Hospital) Ms. Naclerio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Kathryn Swider (Lahey Hospital and Medical Center) Dr. Swider has nothing to disclose.
Joel C. Morgenlander, MD, FAAN (Duke University Medical Center) Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University.
Shannon Anderson, PA, DAAN (Oregon Health & Science University) Mrs. Anderson has nothing to disclose.
Calli L. Cook, DNP, FNP-C, DAAN, FAAN (Emory Healthcare) Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Deena Rodney (Neurology Associates, PA) No disclosure on file
Megan S. Kennelly, RN, NP, DNP, MBA Dr. Kennelly has nothing to disclose.
Elyse Doherty, PA Ms. Doherty has nothing to disclose.
Cassie Meffert, PA (UW Health) Ms. Meffert has nothing to disclose.
Alexander W. King, NP Mr. King has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal.
Scott M. Friedenberg, MD, FAAN (Geisinger Medical Center) The institution of Dr. Friedenberg has received research support from AMA. The institution of Dr. Friedenberg has received research support from Geisinger Medical Center.
Nathaniel M. Robbins, MD (MGB) Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Ariel Nowicki Ms. Nowicki has nothing to disclose.
Fnu Alfandy, DNP (Stanford Health Care) Dr. Alfandy has nothing to disclose.
Kasser Saba, MD Dr. Saba has nothing to disclose.
Pavan Vaswani, MD, PhD (Parkinson’s Disease and Movement Disorders Center / University of Pennsylvania) Dr. Vaswani has received personal compensation in the range of $500-$4,999 for serving as a Travel/training support with Medtronic.
Allison Hennigan, MD The institution of Dr. Hennigan has received research support from NIH .
Holly Bischof, RN, NP Ms. Bischof has nothing to disclose.
Abigail M. Taylor, PA (Mayo Clinic Hopsital) Ms. Taylor has nothing to disclose.
Jason A. Johns, PA (Dartmouth-Hitchcock Medical Center) Mr. Johns has nothing to disclose.
Shivani Ghoshal, MD (Columbia University Medical Center) Dr. Ghoshal has nothing to disclose.
Alyssa Bautista, MD (Columbia University Medical Center) Dr. Bautista has or had stock in Gravity Medical Technology.
John S. Emmett, PA (IU Health Physicians) No disclosure on file
Christopher T. Doughty, MD (Brigham and Women'S Hospital) Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.